Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cue Biopharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 91 | 2 | 100 | +11 |
| Shares | 16.5M | 639 | 17.8M | +1.28M (+7.7%) |
| Value | $187.3M | $7.00K | $86.8M | −$100.4M (−53.6%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Cue Biopharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 104,868 | $511.0K | 0.00% |
| Occudo Quantitative Strategies LP | 53,956 | $263.0K | 0.02% |
| Monaco Asset Management SAM | 45,000 | $220.0K | 0.12% |
| Trexquant Investment LP | 40,070 | $196.0K | 0.01% |
| Walleye Capital LLC | 39,272 | $192.0K | 0.01% |
| XTX Topco Ltd | 35,299 | $172.0K | 0.08% |
| Cubist Systematic Strategies, LLC | 26,633 | $130.0K | 0.00% |
| PDT Partners, LLC | 25,155 | $123.0K | 0.01% |
| Jump Financial, LLC | 25,300 | $123.0K | 0.01% |
| Bridgefront Capital, LLC | 19,968 | $97.0K | 0.12% |
| Corton Capital Inc. | 13,925 | $68.0K | 0.03% |
| Mirabella Financial Services LLP | 11,800 | $58.0K | 0.01% |
| NinePointTwo Capital | 10,582 | $51.0K | 0.01% |
| Wolverine Trading, LLC | 10,080 | $47.0K | 0.00% |
| Amalgamated Bank | 5,025 | $25.0K | 0.00% |
| Amalgamated Financial Corp. | 5,025 | $25.0K | 0.00% |
| Group One Trading, L.P. | 4,760 | $23.0K | 0.00% |
| Spire Wealth Management | 4,000 | $20.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,695 | $13.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,414 | $12.0K | 0.00% |
| FMR LLC | 1,111 | $5.00K | 0.00% |
Sold out (10)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Granite Point Capital Management, L.P. | 110,000 | $1.24M |
| Rafferty Asset Management, LLC | 97,062 | $1.10M |
| Precept Management LLC | 35,000 | $396.0K |
| Belvedere Trading LLC | 19,819 | $178.0K |
| MetLife Investment Management | 11,813 | $133.6K |
| Metropolitan Life Insurance Co | 8,675 | $98.1K |
| Quantbot Technologies LP | 3,030 | $34.0K |
| Nisa Investment Advisors, LLC | 3,020 | $22.0K |
| Rockefeller Capital Management L.P. | 1,132 | $12.0K |
| Northwestern Mutual Wealth Management Co | 70 | $1.00K |
Not filed for Q1 2022 yet (2)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Harbour Investments, Inc. | 439 | $5.00K |
| Reilly Financial Advisors, LLC | 200 | $2.00K |